Ventas, Inc. (NYSE:VTR) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of Ventas, Inc. (NYSE:VTRGet Free Report) have been assigned a consensus rating of “Moderate Buy” from the eighteen research firms that are covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $96.00.

Several analysts recently weighed in on VTR shares. KeyCorp upped their price target on Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $100.00 price objective on shares of Ventas in a research note on Tuesday, June 16th. Jefferies Financial Group boosted their target price on Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday, May 12th. BMO Capital Markets reissued an “outperform” rating and issued a $100.00 target price on shares of Ventas in a report on Monday, May 4th. Finally, Mizuho set a $98.00 target price on Ventas in a research note on Friday, May 22nd.

Check Out Our Latest Analysis on VTR

Ventas Price Performance

Shares of VTR opened at $92.57 on Monday. The stock has a market cap of $45.00 billion, a PE ratio of 168.31, a price-to-earnings-growth ratio of 1.99 and a beta of 0.70. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. Ventas has a fifty-two week low of $62.06 and a fifty-two week high of $92.86. The firm’s 50-day simple moving average is $85.92 and its two-hundred day simple moving average is $83.23.

Ventas (NYSE:VTRGet Free Report) last announced its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a net margin of 4.25% and a return on equity of 2.09%. The business had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.59 billion. During the same period in the prior year, the business posted $0.84 EPS. Ventas’s revenue for the quarter was up 22.0% on a year-over-year basis. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Analysts anticipate that Ventas will post 3.88 earnings per share for the current fiscal year.

Ventas Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, July 16th. Investors of record on Tuesday, June 30th will be paid a $0.52 dividend. The ex-dividend date is Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a yield of 2.2%. Ventas’s payout ratio is presently 378.18%.

Insider Activity

In other Ventas news, Director Walter C. Rakowich sold 1,152 shares of Ventas stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $90.20, for a total value of $103,910.40. Following the completion of the transaction, the director directly owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. The trade was a 3.90% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler bought 2,500 shares of the firm’s stock in a transaction on Wednesday, June 3rd. The stock was purchased at an average cost of $78.81 per share, with a total value of $197,025.00. Following the completion of the acquisition, the director directly owned 19,202 shares of the company’s stock, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their position. The disclosure for this purchase is available in the SEC filing. Corporate insiders own 0.53% of the company’s stock.

Institutional Investors Weigh In On Ventas

Institutional investors and hedge funds have recently made changes to their positions in the company. Dynamic Wealth Strategies LLC purchased a new position in Ventas in the 1st quarter worth approximately $25,000. GoalVest Advisory LLC purchased a new stake in Ventas during the 4th quarter valued at $26,000. Wiser Advisor Group LLC purchased a new stake in Ventas during the 3rd quarter valued at $27,000. IFC & Insurance Marketing Inc. bought a new stake in shares of Ventas in the 4th quarter worth $30,000. Finally, Elyxium Wealth LLC bought a new stake in shares of Ventas in the 4th quarter worth $33,000. Institutional investors own 94.18% of the company’s stock.

Ventas Company Profile

(Get Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

Read More

Analyst Recommendations for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.